OCT Shows Slowing of Structural Glaucoma Progression After SLT 

“Results suggest that SLT may help slow progression of glaucomatous damage over time,” said Raeesah Ahsan, BA, in her presentation.  

By Julie Greenbaum, editor

AI Assistance in Identifying Retinal Disease Biomarkers in OCT Scans

Results demonstrated that use of AI reports in evaluations improved disease detection by 42% overall. 

By Jennifer Ponte Canning, Managing Editor

RESTORE Phase 2b/3 Trial Data Show Lasting BCVA Improvement in RP Patients

MCO-010 demonstrated sustained, clinically meaningful BCVA improvement over 3 years with favorable safety, supporting durable efficacy.

By Jennifer Ford, content director

The Data Bottleneck in AI Adoption

In his keynote talk at the Focus A-Eye Summit, Euan Thomson explained why health care AI progress depends on creating a unified data ecosystem.

By Euan Thomson

Multichannel Femtosecond Laser Surgery Shows Promise for Glaucoma

Data from a study presented at ARVO indicated better outflow could be achieved with 2 channels than with 1.

By Jennifer Ford, content director

New Tools for Imaging Retinal Inflammation

At ARVO 2026, Ethan A. Rossi, PhD, presented data on multimodal AOSLO imaging of immune cells in the living eye.

By Jim Gallagher, senior managing editor

Precision Medicine in Focus at ARVO

ARVO retina program committee member Jay Chhablani, MD, reviews key themes of the meeting, including precision medicine, imaging, and emerging data.

By Jay Chhablani, MD

Solving the Data Challenge in Ophthalmic AI

At ARVO, Cecilia S. Lee, MD, MS, and Aaron Y. Lee, MD, MSCI, discuss barriers to AI deployment in ophthalmology, including interoperability and model development.

By Cecilia S. Lee, MD, MS, Aaron Y. Lee, MD, MSCI